Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.

Smith DJ, Evans R, Craddock N.

J Ment Health. 2010 Apr;19(2):142-56. doi: 10.3109/09638230903469103. Review.

PMID:
20433322
2.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
3.

Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Rybakowski JK.

CNS Drugs. 2013 Mar;27(3):165-73. doi: 10.1007/s40263-013-0040-7. Review.

4.

A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.

Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, Drevets WC, Manji HK.

J Clin Psychiatry. 2009 Apr 21;70(5):699-705. doi: 10.4088/JCP.07m03745.

PMID:
19389332
5.
6.

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.

Washizuka S, Ikeda A, Kato N, Kato T.

Int J Neuropsychopharmacol. 2003 Dec;6(4):421-4.

PMID:
14604458
7.

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.

Michelon L, Meira-Lima I, Cordeiro Q, Miguita K, Breen G, Collier D, Vallada H.

Neurosci Lett. 2006 Aug 7;403(3):288-93. Epub 2006 Jun 19.

PMID:
16787706
8.

The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.

Greil W, Kleindienst N.

Int Clin Psychopharmacol. 1999 Sep;14(5):277-81.

PMID:
10529070
9.

Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.

Rybakowski JK, Czerski P, Dmitrzak-Weglarz M, Kliwicki S, Leszczynska-Rodziewicz A, Permoda-Osip A, Skibinska M, Suwalska A, Szczepankiewicz A, Hauser J.

J Psychopharmacol. 2012 Mar;26(3):368-73. doi: 10.1177/0269881111415736. Epub 2011 Sep 2.

PMID:
21890592
10.

Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.

Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Słopień A, Czerski PM, Leszczyńska-Rodziewicz A, Hauser J.

Pharmacol Rep. 2005 Nov-Dec;57(6):761-5.

11.

Biological predictors of lithium response in bipolar disorder.

Ikeda A, Kato T.

Psychiatry Clin Neurosci. 2003 Jun;57(3):243-50. Review.

12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
13.

Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.

Baethge C, Gruschka P, Berghöfer A, Bauer M, Müller-Oerlinghausen B, Bschor T, Smolka MN.

J Affect Disord. 2004 Apr;79(1-3):43-50.

PMID:
15023479
14.

Pharmacogenetics of lithium response in bipolar disorder.

Alda M.

J Psychiatry Neurosci. 1999 Mar;24(2):154-8. Review.

15.

[Long-term treatment of bipolar disorder: how should we use lithium salts?].

Del Grande C, Muti M, Musetti L, Pergentini I, Corsi M, Turri M, Soldani I, Corsini GU, Dell'Osso L.

Riv Psichiatr. 2012 Nov-Dec;47(6):515-26. doi: 10.1708/1178.13058. Italian.

PMID:
23160112
16.

Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine.

Passmore MJ, Garnham J, Duffy A, MacDougall M, Munro A, Slaney C, Teehan A, Alda M.

Bipolar Disord. 2003 Apr;5(2):110-4.

PMID:
12680900
17.

Open-label lithium for the treatment of adolescents with bipolar depression.

Patel NC, DelBello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM.

J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):289-97.

PMID:
16540813
18.

Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.

Baldessarini RJ, Tondo L, Floris G, Hennen J.

J Affect Disord. 2000 Dec;61(1-2):13-22.

PMID:
11099736
19.

Can the response to mood stabilizers be predicted in bipolar disorder?

Geoffroy PA, Bellivier F, Leboyer M, Etain B.

Front Biosci (Elite Ed). 2014 Jan 1;6:120-38. Review.

20.

Pharmacogenetic aspects of bipolar disorder.

Alda M.

Pharmacogenomics. 2003 Jan;4(1):35-40. Review.

PMID:
12517284

Supplemental Content

Support Center